Behind the merger and relocation of GTx, the once-promising pillar of Memphis’ ‘biotech core’


“We had a commercial team, a marketing team, and the sales organization. … At the last minute, the FDA decided the data was not sufficient for approval.”

Previous Chase Bank is coming to St. Louis
Next Emtora Biosciences CEO talks new name, focus and finish line